Curocell Inc.
A clinical-stage biotech developing CAR-T therapies for blood cancers.
372320 | KO
Overview
Corporate Details
- ISIN(s):
- KR7372320002
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 국제과학16로 11, 대전광역시
- Website:
- https://curocellbtx.com/
- Sector:
- Manufacturing
Description
Curocell Inc. is a clinical-stage biotechnology company specializing in the development of Chimeric Antigen Receptor T-cell (CAR-T) therapies. The company focuses on engineering a patient's own immune cells to recognize and eliminate cancer, primarily targeting blood cancers. Curocell's proprietary OVIS™ technology is an immune checkpoint receptor platform designed to enhance the efficacy of CAR-T treatments by overcoming the immunosuppressive tumor microenvironment. The company has advanced its lead candidate, anbalcabtagene autoleucel (Limkato), through Phase 2 clinical trials and operates a state-of-the-art GMP facility for the production of its advanced cell therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 75.9 KB | ||
| 2025-08-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-08-13 00:00 |
반기보고서 (2025.06)
|
Korean | 1.6 MB | ||
| 2025-08-08 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인신청) (CRC01(안발캅타젠오토류셀, 안발셀)의 B세포 급성 림프모구성 성인…
|
Korean | 12.5 KB | ||
| 2025-08-04 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-08-04 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 101.7 KB | ||
| 2025-08-01 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청등결정) (CD19 CAR-T 치료제 CRC01의 전신 홍반성 루푸스 제1,2…
|
Korean | 12.0 KB | ||
| 2025-07-23 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-07-21 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-07-09 00:00 |
자산재평가결과(자율공시)
|
Korean | 9.4 KB | ||
| 2025-07-02 00:00 |
자산재평가실시결정(자율공시)
|
Korean | 5.0 KB | ||
| 2025-06-30 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청) (CD19 CAR-T 치료제 CRC01의 전신 홍반성 루푸스 제1,2상 임…
|
Korean | 8.6 KB | ||
| 2025-05-14 00:00 |
분기보고서 (2025.03)
|
Korean | 1.5 MB | ||
| 2025-04-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB |
Automate Your Workflow. Get a real-time feed of all Curocell Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Curocell Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Curocell Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
